| Dr Mark Bennett Weiss, MD | |
|
2001 Marcus Ave, Suite W84, New Hyde Park, NY 11042-1011 | |
| (516) 775-3937 | |
| (516) 775-2808 |
| Full Name | Dr Mark Bennett Weiss |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 44 Years |
| Location | 2001 Marcus Ave, New Hyde Park, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114079746 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 146915 (New York) | Primary |
| Entity Name | Family Ophthalmology Of Long Island Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316100746 PECOS PAC ID: 3577636620 Enrollment ID: O20080722000699 |
News Archive
Representatives of the state boards that oversee licensing of the nation's physicians, nurses and pharmacists have gathered in Washington, D.C. this week for the first-ever Tri-Regulator Symposium, an event that will examine a variety of health care issues.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
Data published in the January issue of Innovations in Clinical Neuroscience, www.psychiatrymmc.com, suggest when L-methylfolate, a medical food available commercially as Deplin®, and by prescription, is used for dietary management of depression in combination with an antidepressant drug at the start of depression therapy, it results in significantly more patients experiencing major improvement and more rapid improvement than antidepressant monotherapy alone.
In a new publication from Cardiovascular Innovations and Applications; Sharen Lee, Gary Tse, Xin Wang, Adrian Baranchuk and Tong Liu from Laboratory of Cardiovascular Physiology, Hong Kong, China, Second Hospital of Tianjin Medical University, Tianjin, China and Queen's University, Kingston, Ontario, Canada consider ST-segment depression in leads I and aVL.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Bennett Weiss, MD 2001 Marcus Ave, Suite W84, New Hyde Park, NY 11042-1011 Ph: (516) 775-3937 | Dr Mark Bennett Weiss, MD 2001 Marcus Ave, Suite W84, New Hyde Park, NY 11042-1011 Ph: (516) 775-3937 |
News Archive
Representatives of the state boards that oversee licensing of the nation's physicians, nurses and pharmacists have gathered in Washington, D.C. this week for the first-ever Tri-Regulator Symposium, an event that will examine a variety of health care issues.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 14-day, phase IIa clinical trial evaluating IDX184, a novel liver-targeted nucleotide prodrug of 2'-methyl guanosine monophosphate, in HCV-infected patients.
Data published in the January issue of Innovations in Clinical Neuroscience, www.psychiatrymmc.com, suggest when L-methylfolate, a medical food available commercially as Deplin®, and by prescription, is used for dietary management of depression in combination with an antidepressant drug at the start of depression therapy, it results in significantly more patients experiencing major improvement and more rapid improvement than antidepressant monotherapy alone.
In a new publication from Cardiovascular Innovations and Applications; Sharen Lee, Gary Tse, Xin Wang, Adrian Baranchuk and Tong Liu from Laboratory of Cardiovascular Physiology, Hong Kong, China, Second Hospital of Tianjin Medical University, Tianjin, China and Queen's University, Kingston, Ontario, Canada consider ST-segment depression in leads I and aVL.
› Verified 9 days ago
Dr. Paul Kritikos, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 Union Tpke, Suite 105, New Hyde Park, NY 11040 Phone: 516-326-2275 Fax: 516-326-2251 | |
Stephen Haug, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1991 Marcus Ave, 2nd Floor, New Hyde Park, NY 11042 Phone: 516-354-1600 Fax: 516-941-4677 | |
Norman W. Reinach, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1915 New Hyde Park Rd, New Hyde Park, NY 11040 Phone: 516-775-6640 Fax: 516-775-7069 | |
Dr. Martin J Fox, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 410 Lakeville Rd, Ste 300, New Hyde Park, NY 11042 Phone: 516-488-2750 Fax: 516-488-7407 | |
Howard Adam Lane, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1981 Marcus Ave Ste E115, New Hyde Park, NY 11042 Phone: 516-627-5113 Fax: 513-365-2817 | |
Dr. William C Boozan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1915 New Hyde Park Rd, New Hyde Park, NY 11040 Phone: 516-775-6640 Fax: 516-775-7069 |